We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Erba Mannheim Showcases Exciting New Introductions at MEDLAB Middle East 2021

By LabMedica International staff writers
Posted on 22 Jun 2021
Print article
Illustration
Illustration
Erba Mannheim (London, UK) showcased some of its exciting new introductions at MEDLAB Middle East 2021, the MENA region’s largest medical laboratory exhibition and congress, which took place at the Dubai World Trade Centre from 21-24 June.

Erba introduced the fully automated ELAN 30s, a complete solution for lab ELISA workflow that allows users to develop new, flexible analytical workflows by taking advantage of smart scheduling software. By combining up to six different assays in a single run users can break the traditional two or four plate mold and create ‘clinical panel’ based workflows. Multiple reporting formats enhance the final steps of the process and allow the user to report faster with more convenience.

Erba also exhibited its new hematology analyzers - the H360 automated 3 part differential analyzer and H560 automated 5 part differential hematology analyzer, alongside the Elite 580 automated 5-part hematology analyzer with continuous loading capacity. Also on display at this year’s MEDLAB Middle East 2021 edition was the LAURA XL fully automated urine analyzer that combines urine strip reading with digital microscopy. The two-module integrated station consists of one module which performs analysis of the chemical parameters of urine on diagnostic test strips using reflective photometry; and one module performs urinary sediment examination using automated microscopy technology in a format compatible with manual microscopy. In addition, Erba showcased the next generation electrolyte analyzer, EC 90 ISE, which employs cutting edge technology to take laboratory electrolyte measurements to new heights. The EC 90 electrolyte analyzer features next generation thick film, maintenance-free electrodes in all-in-one sensor cartridge.

Alongside these new products, the company presented the ErbaMDx SARS-COV-2 RT-PCR kit, a molecular diagnostic test that aids the detection and diagnosis of COVID-19 infections and is based on latest nucleic acid amplification technologies. It is a real-time reverse transcriptase PCR test that has been developed utilizing universally trusted priming sites with updated primer sequences to maximize long term performance.

Related Links:
Erba Mannheim

New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
C-Reactive Protein Assay
OneStep C-Reactive Protein (CRP) RapiCard InstaTest
New
Silver Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.